Observational study · people

Melanotan I: EPP quality-of-life score rose from 44% to 75%

Checked against the paper Observational studyPublished by PepVault

The takeaway

For people with EPP, this Dutch cohort links afamelanotide treatment to better disease-specific quality of life and social functioning, measured with patient questionnaires.

Kind
Observational study
Studied in
People
Number studied
121
Published
2023
Journal
J Dermatol

What they tested

The team wanted to learn how erythropoietic protoporphyria (EPP), a condition where light exposure brings on severe burning pain, affects daily and social life, and how that changed during afamelanotide treatment.

How the study was done

A single-center, prospective observational study that followed 121 adults with EPP at Erasmus MC Rotterdam in the Netherlands over time. Patients filled in questionnaires on their background, health and social life, including two general quality-of-life surveys (DS-14 and SF-36) and one made for EPP (EPP-QoL), before and during afamelanotide treatment.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Melanotan I? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Scores on EPP-QoL, the EPP-specific quality-of-life survey, went from 44% before treatment to 75% during afamelanotide treatment (p < 0.001). On the SF-36 social functioning scale, patients started below the Dutch population (74.4 ± 27.3 vs. 84.0 ± 22.4) and reached 84.3 ± 20.9 during treatment (p = 0.001). Among the 27.4% of patients with a Type-D personality, social inhibition scores improved during treatment (p = 0.019). Full- and part-time work went from 59.5% to 69.9%, but this change was not statistically significant (p > 0.05).

What it doesn’t show

This was a before-and-during comparison at one hospital with no control group and no placebo, so other factors could explain part of the change. The rise in employment did not reach statistical significance.

The paper

Wensink et al. Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotide. J Dermatol. 2023.

The compound

More studies on Melanotan I

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Melanotan I? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo